Clinical Trial Update: Esomeprazole to Reduce Organ Failure in Sepsis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating esomeprazole for reducing organ failure in patients with sepsis and septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Esomeprazole (Esomeprazole)

Snippet

Sponsor: Università Vita-Salute San Raffaele | Conditions: Sepsis, Septic Shock | Phase 3 | Status: COMPLETED